Crinetics Pharmaceuticals Inc (CRNX)
Cost of Revenue
$354.00K
TTM · Period ending: · USD
CRNX Cost of Revenue
Latest reported$354.00Kperiod ending
Latest reported$354.00Kperiod ending
CRNX TTM Cost of Revenue ($0.00 → $354.00K)
TTM cost of revenue
High-resolution chart · PNG
CRNX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 354,000 | |
| 200,000 | |
| 0 | |
| 66,566,000 | |
| 128,471,000 | |
| 128,471,000 | |
| 128,471,000 | |
| 107,485,000 | |
| 45,580,000 | |
| 45,580,000 | |
| 45,580,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 21,580,000 | |
| 42,067,000 | |
| 59,651,000 | |
| 59,651,000 | |
| 38,071,000 | |
| 17,584,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |